Earnings
Dexcom Finished A $1 Billion Buyback In Nine Months, Then Approved Another
Third-quarter operating cash flow fell 51% from a year earlier as inventory climbed and a second $1.00 billion repurchase program followed.
DXCM
DexCom (DXCM) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
DexCom CEO Still Expects A Medicare Coverage Decision This Year, Backed By Connect Trial
Jake Leach says the timing for type 2 non-insulin coverage is unchanged as DexCom reports 14% U.S. revenue growth.
Earnings
DexCom Says Lost PBM Coverage Is Under 4% Of U.S. Revenue And Won't Dent 2027 Much
The CFO said a pharmacy-benefit manager setback should not significantly hurt next year's results, as payer and pricing questions dominated the call.
Earnings
Dexcom Raises Margin Targets And Plans $1 Billion Buyback After Sales Climb 11%
The glucose-monitor maker's U.S. revenue grew 14% in the third quarter, and it lifted 2026 margin guidance.